Leadership & Pay · · GlobeNewswire
X4 Pharmaceuticals Appoints Kelly Gold to Board of Directors
XFORX4 Pharmaceuticals, Inc
X4 Pharmaceuticals announced the appointment of Kelly Gold to its Board of Directors as an independent director and Audit Committee member, effective July 1, 2026. Ms. Gold currently serves as Chief Financial Officer at CAMP4 Therapeutics and brings experience in corporate finance, investor relations, and strategic planning from previous roles at Biogen and Deutsche Bank. X4 Pharmaceuticals is a biotechnology company focused on developing therapies for rare hematology diseases.